ArisGlobal Achieves Record Customer Growth and Product Innovation in First Half 2024
Eight net new LifeSphere customers, 300% YoY increase in customer go-lives, and delivering innovation via LifeSphere NavaX
Hans van Leeuwen
Global Head of Regulatory Operations – Astellas
Steve Gens
Managing Partner – Gens & Associates
Michael Sonntag
Director, Global Regulatory Affairs & PV – Wörwag Pharma
See where AI and automation drive the greatest time and cost savings.
Eight net new LifeSphere customers, 300% YoY increase in customer go-lives, and delivering innovation via LifeSphere NavaX
ArisGlobal places all customers at the core of its operations.
Montreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.
Montreal Health Innovations Coordinating Center (MHICC), a fast-growing contract research organization, believes LifeSphere’s innovative use of automation and Generative AI is aligned with its pharmacovigilance plans.
End-to-end functionality helps cut skyrocketing costs of compliance and removes workflow inefficiencies.
The top-tier life sciences company will standardize its Safety operations on the cloud-powered technology platform, LifeSphere, which is propelling life sciences GenAI use cases.
Nuckols will apply decades of both life sciences and technology leadership to enhance innovation and customer focus at ArisGlobal
The international survey reveals that there is currently a pronounced gap between Life Sciences organizations’ intentions and their actual use of next-generation technologies.
LifeSphere Clarity drives efficiencies and reinvents the way Boehringer Ingelheim’s ...
Advanced Intake™ demonstrates up to 65% efficiency gains in adverse ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved